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Abstract
Background: Enterococci have emerged as an important opportunistic pathogen causing life-threatening infections
in hospitals. The emergence of this pathogen is associated with a remarkable capacity to accumulate resistance to
antimicrobials and multidrug-resistance particularly to vancomycin, erythromycin and streptomycin have become a
major cause of concern for the infectious diseases community. In this paper, we report the prevalence of Enterococcus
in respect to species distribution, their virulence and antibiogram profiles.
Methods: Four hundred fecal samples were collected from two piggery farms in the Eastern Cape Province of South
Africa. Enterococcus species were isolated and confirmed with generic specific primers targeting the tuf gene (encoding
elongation factor). The confirmed isolates were speciated with enterococci species specific primers that aimed at
delineating them into six species that are commonly associated with infections in humans. Antibiotic susceptibility
testing was performed by disc diffusion method. Six virulence genes and antimicrobial resistance profiles of the isolates
were evaluated molecularly.
Results: Molecular identification of the presumptive isolates confirmed 320 isolates as Enterococcus spp. Attempt at
speciation of the isolates with primers specific for E. faecalis, E. durans, E. casseliflavus, E. hirae and E. faecium delineated
them as follows: E. faecalis (12.5 %), E. hirae (31.25 %), E. durans (18.75 %) and E. faecium (37.5 %) while E. casseliflavus
was not detected. All the isolates were resistant to vancomycin, streptomycin and cloxacillin, and to at least two
different classes of antibiotics, with 300 (93.8 %) isolates being resistant to five or more antibiotics. Also, three out of
the six virulence genes were detected in majority of the isolates and they are Adhesion of collagen in E. faecalis (ace)
(96.88 %), gelatinase (gelE) (93.13 %) and surface protein (esp) (67.8 %).
Conclusion: There was high prevalence of multi-resistant vancomycin Enterococcus spp. (VREs) in the fecal samples of
pigs in the farms studied, and this poses health implications as vancomycin is an important drug in human medicine.
Further studies are needed to determine the spread of vancomycin resistance among bacteria of human origin in the
communities.
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Background
Generally, antibiotic-resistant pathogens are able to cause
a major clinical challenge in both human and animals.
Enterococcus spp., ubiquitous in nature and a common
commensal of the intestinal microbiota of humans and
animals, have emerged as one of the most prevalent noso-
comial pathogens worldwide [1]. Several factors such as
their propensity and inherent ability to acquired resistance
to antimicrobials [2], putative virulence traits, biofilm
forming capability [3], and ability to horizontally transfer
antimicrobial resistance and virulence determinants to
other bacteria [4] are attributable to these abilities.
Enterococcus spp. are Gram-positive bacteria known to
possess a low level of pathogenicity and can cause urinary
tract infections, endocarditis, peritonitis, among other dis-
eases. [5, 6]. Until 1988, Vancomycin was one of the pre-
ferred antibiotics for the treatment of infections caused by
Enterococcus spp. But this seems to have changed when the
first vancomycin-resistant Enterococcus spp. (VREs) were
isolated and identified in Great Britain[7]. Also, VREs have
been detected and isolated in many countries throughout
the world thus heightening the sense of urgency regarding
the global presence of antibiotic resistant enterococci[8–
10]. As infections caused by VREs are difficult to treat, VRE
should be considered a dangerous pathogen as it could eas-
ily spread to people with compromised immune system.
The risk of death from vancomycin-resistant enterococci
(VRE) is has been reported to be about 75 %, compared
with 45 % for those infected with a susceptible strain [11].
According to the degree of resistance to vancomycin and
teicoplanin, as well as the origin and transferability of the
antibiotic resistance genotype, VREs are categorized as ex-
pressing the vanA, vanB, or vanC, vanD, vanE and vanG
phenotypes [12, 13]. The vanA phenotype shows a high
level of resistance to both vancomycin and teicoplanin,
while the vanB phenotype shows various levels of resist-
ance to vancomycin but is sensitive to teicoplanin. The
vanC phenotype can be further divided into 3 classes,
vanC-1, vanC-2, and vanC-3; vanC-2 and vanC-3 are
expressed as vanC-2/3 because of their similar genetic se-
quence [14, 15]. Vancomycin resistance among entero-
cocci spread via the dissemination of mobile genetic
elements of variants of the vanA-type element Tn1546
mostly located on conjugative plasmids [16, 17].
A variety of antibiotics are applied at both therapeutic
and sub-therapeutic levels in the management of farm
animals. Tylosin, a member of the macrolide family is
widely used as antimicrobial growth promoters (AGPs).
The use of avoparcin has been associated with high level
of vancomycin-resistant enterococci in farm animals [18].
The possibility of transmission of bacteria from animals to
humans is not limited to zoonotic diseases and the selec-
tion of a reservoir of resistant opportunistic human patho-
gens and possible transmissible resistance determinants
through the indiscriminate use of antimicrobials in farm
animal managements may have undesirable consequences
for human health [18]. The ability of Enterococcus spp. to
acquire antibiotic resistance through transfer of plasmids
and transposons, chromosomal exchange, or mutation
presents a significant challenge for therapeutic measures.
In addition to this inherent capacity of enterococci to ac-
quire resistance determinants, they possess several viru-
lence factors. The virulence of this organism is associated
with several genes such as ace (collagen binding cell wall
protein), acm (surface-exposed antigen), agg (aggregative
pheromone-inducing adherence to extra-matrix protein),
esp (enterococcal surface protein), hyl (hyaluronidase),
cad1 (pheromone cAD1 precursor lipoprotein), the
cAM373 gene (sex pheromone cAM373 precursor), the
cCF10 gene (pheromone cCF10 precursor lipoprotein), cob
(pheromone cOB1 precursor/lipoprotein, YaeC family),
cpd1 (pheromone cPD1 lipoprotein), cylABLM (hemolysin),
efaAEfs (endocarditis-specific antigen), sagA (secreted anti-
gen), and gelE (gelatinase) [19, 20]. These virulence factors
have been reported in enterococci isolated from food of
animal origin [21].
The Eastern Cape Province of South Africa is largely
rural and agrarian with many commercial piggery farms.
The use of antibiotics to manage animal productivity is a
common phenomenon and the impact of bacteria with
resistance determinant shed into the environment through
fecal materials of animal possess a huge epidemiological
problem considering the fact that the province has one of
the highest HIV/AIDS prevalence in the country. In this
paper, we report on the virulence and antimicrobial resist-
ance profiles of Enterococcus spp. isolated from fecal sam-
ples collected from piggery farms in the Nkonkonbe
municipality in the Eastern Cape Province of South Africa
Table 1 List of primers and control strains





















HI1 CTTTCTGATATGGATGCTGTC 187 23
HI2 TAAATTCTTCCTTAAATGTTG
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as part of our larger study on the reservoirs of antibiotic
resistance in the environment.
Materials and methods
Ethical clearance
Ethical clearance was obtained from the University of
Fort Hare ethics committee prior to sample collection
and cooperation was sought from farmers from whose
farms samples were collected.
Study population and sampling
Details on the study population and sampling proce-
dures are as follows. Briefly, samples were collected from
two commercial piggery farms in Nkonkonbe municipality
within the Amathole Districts of Eastern Cape Province.
A total of 400 samples from two farms were collected for
the study. Rectal fecal samples were collected from
individual breeder pigs using sterile swab sticks and to
avoid duplication of sampling, the pigs were sampled
while locked in their respective cages. After collection,
samples were shipped on ice to the University of Fort
Hare Microbiology laboratory for immediate processing.
Data on antibiotic type and treatment history were col-
lected with the purpose of describing the study popula-
tion. Inventory of the antibiotics in the farmers
refrigerators were taken during sampling. Sampling was
done between June and August, 2014 at an interval of two
samplings fortnightly.
Laboratory detection of Enterococcus spp.
The swab sticks were used to inoculate trypticase soya
broth and incubated at 37 °C for 18 to 20 h. These were
then sub-cultured onto Bile Aesculin Azide agar and in-
cubated at 37 °C for 24 h. Black dew drop colonies were
assumed presumptive for Enterococcus species. One colony
per plate was picked into a sterile trypticase soya broth and
further incubated for 18 h at 37 °C for glycerol stock prep-
aration and preservation at–80 °C for future use.
DNA Extraction
To extract genomic DNA from the previously stored
glycerol stocks, isolates were resuscitated in a 5 ml Todd
Hewitt broth at 37 °C for 20 h and cells were recovered
from 2 ml of the broth in a sterile Eppendorf and centri-
fugation was done at 5,000 rpm for 10 min. The super-
natant was discarded and the cell deposit washed with
normal saline and further centrifuged at 5,000 rpm for
3 min. The cell pellet was then re-suspended in a micro-
centrifuge tube containing rapid lysis buffer:-100 mM
Table 3 Oligonucleotides used in this study to amplify the enterococci virulence genes











ACE 1 AAAGTAGAATTAGATCCACAC 320 56 25
Gel Gelatinase gel E1 AGTTCATGTCTATTTTCTTCAC 402 56 25
gel E2 CTTCATTATTTACACGTTTG
EfaA E. faecalis antigen A efaA1 CGTGAGAAAGAAATGGAGGA 499 56 25
efaA2 CTACTAACACGTCACGAATG
Esp Surface protein Esp 46 TTACCAAGATGGTTCTGTAGGCAC 913 58 32
Esp 47 CCAAGTATACTTAGCATCTTTTGG
CylA Cytolisin Cyl I ACTCGGGGATTGATAGGC 688 56 32
Cyl Iib GCTGCTAAAGCTGCGCTT
Hyl Hyaluronidase Cyl Iib GCTGCTAAAGCTGCGCTT 276 56
Hyl n1 ACAGAAGAGCTGCAGGAAATG Hyl n2
GACTGACGTCCAAGTTTCCAA
Table 2 Oligonucleotide primers used in this study to identify
vancomycin resistance genes
Gene(s) Size (bp) Primer sequence (5' to 3') Region Ref
vanA 314 AF-GCGCGGTCCACTTGTAGATA 105-124 7
AR-TGAGCAACCCCCAAACAGTA 399-418
vanB 220 BF-AGACATTCCGGTCGAGGAAC 844-863 7
BR-GCTGTCAATTAGTGCGGGAA 1044-1063
VanC-1 402 C1F-ATCCAAGCTATTGACCCGCT 290-309 7
C1R-TGTGGCAGGATCGTTTTCAT 672-691
VanC-2/3 582 C2F-CTAGCGCAATCGAAGCACTC 100-119 7
C2R-GTAGGAGCACTGCGGAACAA 662-681
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NaCl, 10 mM Tris–HCl pH8.3, 1 mM EDTA pH9.0; 1 %
Triton X-100, boiled for 15 min followed by centrifuga-
tion at 10,000 rpm and supernatant collected and stored
at–20 °C for future use.
Molecular confirmation of the isolates
This preliminary approach stated above was then
followed by polymerase chain reaction (PCR) identifica-
tion analysis with Enterococcus genus-specific primers
Ent 1 and Ent 2, as previously reported [22] with E.
faecium ATCC19434 serving as the positive control. The
tuf gene of the genus Enterococcus was amplified by
PCR which was performed in a 25-μl mixture of 5x buffer
(supplied with Taq polymerase), 2.5 mmol/l of MgCl2, 2.5
u of Taq DNA polymerase, 200 μmol/l of each deoxynu-
cleoside triphosphate, and 10 pmol of each primer Ent1
5′-TACTGACAAACCATTCATGATG-3′ and Ent2 R: 5′-
AACTTCGTCACCAACGCGAAC-3′. The PCR mixture
was subjected to a 4-min denaturation step at 94 °C,
followed by 35 cycles of 60 s at 94 °C, 60 s at 53 °C, and
60 s at 72 °C, and a final elongation step for 5 min at
72 °C. Verification of PCR products were performed in
a 2 % agarose gel electrophoresis at 110 V for 45 min,
visualized after staining with ethidium bromide in AL-
LIANCE.4.7 transilluminator and photographed.
Species identification
A multiplex polymerase chain reaction (PCR) was performed
for Enterococcus species identification. Amplification of the
genes related to the species-specific identification of E.
faecalis, E. faecium, E. hirae, E. durans, and E. casseliflavus
were performed as described previously by Jackson [23].
Two PCR master mixes consisting of different primer
sets were prepared. Group 1 was E. durans, E. faecalis,
and E. casseliflavus, and group 2 was E. faecium and E.
hirae. The Dream Taq PCR Master Mix (2X) consisting
of 4 mM MgCl2, 0.4 mM deoxynucleoside triphosphate
mix and Taq polymerase enzyme (Thermo Scientific.)
and 10pMol of each primer pair was added to consti-
tuted the reaction mixture in a PCR tube. Primers used
are indicated in (Table 1). PCRs were performed in a
final volume of 25 μl consisting of 20 μl of master mix
and 5 μl of DNA template. Following an initial de-
naturation at 95 °C for 4 min, products were amplified
in 30 cycles of denaturation at 95 °C for 30 s, annealing
at 52 °C (E.. faecalis, E. durans and E. casseliflavus) or
48 °C (for E. faecium and E. hirae) for 1 min, and
elongation at 72 °C for 1 min followed by a final exten-
sion at 72 °C for 7 min. Five microliters of product was
electrophoresed on a 2 % Tris-borate-EDTA agarose gel
containing 2 μg of ethidium bromide/ml to verify amplifi-
cation of the targeted genes at 110 V for 45 min. DNA
molecular weight marker 100 bp was used as the standard
and photographed under UV light transilluminator (ALLI-
ANCE 4.7) Molecular Imager Gel Doc.
Antibiotic sensitivity testing
The antimicrobial susceptibility of all isolates were
assessed according to the Kirby-Bauer disk-diffusion
method [24] making use of antibiotic discs (MAST
DIAGNOSTICS) which were dispensed by automated
disc dispenser on Muller Hinton agar (MHA). The
following antibiotic impregnated discs were used: clin-
damycin (2 μg), imipenem (10 μg), neomycin (30 μg),
215bp
187bp
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Fig. 2 Gel electrophoresis of multiplex PCR product for the speciation of the isolates positive for Enterococcus genus. Lane 1 is 100 bp ladder,
lane 2 negative control and lanes 3 to 14 are E. hirae (187 bp) and E. faecium (215 bp), representatives of the positive isolates identified in this study
112bp
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Fig. 1 Gel electrophoresis of PCR product of amplification of tuf gene for confirmation of Enterococcus genus. Lane 1 is the 100bpMWM, lane 2
is the negative control, 3 is positive control E. faecium ATCC19434 while lanes 4 to 18 are amplicons derived from study isolates
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streptomycin (10 μg), vancomycin (30 μg), penicillin G
(10 μg), amoxicillin-clavulanic acid (10 μg), ciprofloxacin
(5 μg), cephalothin (30 μg), cloxacillin (5ug), erythromycin
(15ug) and amikacin (30ug). In the evaluation of the
results, strains displaying intermediate resistance were
regarded as resistant. All antibiotic discs contained the
CLSI [24] approved concentration. The interpretations
of zones of inhibition were carried out according to
the [24] performance standards for antimicrobial sus-
ceptibility testing guideline.
Detection of antibiotics resistance genes
Polymerase chain reaction was performed on isolates that
were resistant phenotypically to vancomycin for the pres-
ence of putative vancomycin resistance (vanA, vanB,
vanC1, and vanC2/3) genes from the previously extracted
genomic DNA. PCRs were performed in a BioRad Ther-
mal Cycler (CA, Foster City, USA). The oligonucleotide
primers for PCR amplifications were synthesized by
Inqaba Biotech (Pretoria, South Africa). Primer sequences
for vanA, vanB, vanC1, vanC2/3 genes were those previ-
ously described by Nam [7] and the list of the specific
primers and their amplification products are shown in
Table 2. The reactions were performed as singleplex in a
total volume of 25 μl, using 5 μl of cell lysate as DNA tem-
plate, 10 pMol of each of the eight primers, 12 μl of
Dream Taq master PCR mix (Inqaba Biotech, Pretoria,
South Africa) and 6 μl of PCR water grade. Amplification
conditions were as follows: a first denaturation step of 94 °C
for 3 min, 35 cycles of denaturation at 94 °C for 1 min, an-
nealing at 56.5 °C for 1 min, extension at 72 °C for 1 min,
followed by an elongation step at 72 °C for 10 min. The
PCR products were analyzed on 2 % agarose gel con-
taining 10 μl of ethidium bromide, electrophoresed at
110 V for 45 min and visualized under UV transillumi-
nator (ALLIANCE 4.7) and photographed.
The presence of erm(B) and strA genes that could have
been responsible for the observed resistance to erythro-
mycin and streptomycin were examined by using the
primers pairs erm(B) (ermBN1: 5′-CGAGTGAAAAAG
TACTCAACCA-3′, ermBN2: 5′-CGGTGAATATCCAA
GGTACG-3′) and strAF: 5′-ATCTGTCTGGAGCGGAT
TTG-3′ and strAR:5′-CCAGTTCTCTTCGGCGTTAG-3′
respectively. In each PCR tube, a reaction mixture (25 μl)
containing 5 μl bacterial DNA, 12 μl of Dream Taq Master
Mix (Thermo Scientific) 10 pMol each of primer and
Table 4 Antibiotic resistance profiles of E. faecium, E. hirae, E. durans and E. faecalis isolates obtained from pig faecal samples
Antibiotics E.faecium E.hirae E.durans E.faecalis
R S R S R S R S
VANCOMYCIN 120(100 %) 0(0 %) 100(100 %) 0(0 %) 60(100 %) 0(0 %) 40(100 %) 0(0 %)
CEPHALOTHIN 109(90.8 %) 11(9.2 %) 93(93 %) 7(7 %) 50(83 %) 10(17 %) 34(85 %) 6(15 %)
PENICILLIN G 114(95 %) 6(5 %) 98(98 %) 2(2 %) 45(75 %) 15(25 %) 35(87 %) 5(13 %)
CIPROFLOXACIN 113(94.1 %) 7(5.9 %) 87(87 %) 13(13 %) 30(50 %) 30(50 %) 18(45 %) 22(55 %)
STREPTOMYCIN 120(100) 0(0 %) 100(100 %) 0(0 %) 60(100 %) 0(0 %) 40(100 %) 0(0 %)
AMOXIL/ CLAV 20(16.7 %) 100(83.3 %) 15(15 %) 85(85 %) 15(25 %) 45(75 %) 14(35 %) 26(65 %)
AMIKACIN 117(97.5 %) 3(2.5 %) 95(95 %) 5(5 %) 40(66.7 %) 20(33.3 %) 20(50 %) 20(50 %)
CLINDAMYCIN 116(96.66 %) 4(3.44 %) 100(100 %) 0(0 %) 60(100 %) 0(0 %) 40(100 %) 0(0 %)
ERYTHROMYCIN 118(98.3 %) 2(1.7 %) 100(100 %) 0(0 %) 58(96.7 %) 2(3.3 %) 40(100 %) 0(0 %)
NEOMYCIN 120(100 %) 0(0 %) 98(98 %) 2(2 %) 42(70 %) 18(30 %) 40(100 %) 0(0 %)
IMIPENEM 10(8.3 %) 110(91.7 %) 9(9 %) 91(91 %) 20(33 %) 40(77 %) 13(32.5 %) 27(68.5 %)
CLOXACILLIN 120(100 %) 0(0 %) 100(100 %) 0(0 %) 60(100 %) 0(0 %) 40(100 %) 0(0 %)
360bp
299bp
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Fig. 3 Gel electrophoresis of PCR product multiplex PCR detection of E. faecalis, E. durans species isolated in this study. Lane 1 is 100 bp ladder, lane 2
negative control and lanes 3 to 13 are E. faecalis (360 bp) and E. durans (299 bp), representatives of the positive isolates identified in this study
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6ul of water of PCR grade was prepared. The reaction
mixture in the tube was subjected to 35 PCR cycles of
denaturation at 94 °C (1 min), annealing at 55 °C and
56.5 °C respectively for erm (B) and strA (1 min), and
elongation at 72 °C (1 min) in a BioRad thermal cycler
with a final elongation at 72 °C for 7 min. PCR prod-
ucts with specific sizes of the resistance genes were
detected by agarose gel electrophoresis at 110 V for
45 min, stained with ethidium bromide and visualized
under UV light in a transilluminator (ALLIANCE 4.7).
Screening for virulence genes in Enterococcus spp.
The presence of virulence genes were investigated from
the previously extracted genomic DNA for all the con-
firmed isolates. Specific primers for the following five
virulence genes: ace, efaA, cylA, gelE, esp and hylE were
used as previously described by [25]. The list of the
primers used and their amplification products are re-
ported in Table 3. The reactions were performed in a
total volume of 25 μl using 5 μl of DNA, 10 pmol of
each primer, 12 μl of PCR Dream Taq Master Mix
(Thermo Scientific). PCR conditions for ace and gelE
genes were denaturation at 94 °C for 1 min, annealing at
50 °C for 1 min, extension at 72 °C for 1 min for 35 cy-
cles and final extension at 72 °C for 10 min while those
for the amplification of the efaA, esp, cylA and hylE
genes were as follows: denaturation at 94 °C for 1 min,
annealing at 56.5 °C for 1 min, extension at 72 °C for
1 min, for 35 cycles with a final extension at 72 °C for
10 min. The PCR products were analyzed on 2 % agar-
ose gel containing ethidium bromide, electrophoresed at
110 V for 45 min, visualized under UV transilluminator
(ALLIANCE 4.7) and photographed.
Results
A total of 320 presumptive isolates were recovered from
the 400 fecal samples collected from the breeder pigs in
a 600 and 3,000 sizes heard that have been exposed to
tylosin, advocin (danofloxacin), ampicillin, and penicillin
G antibiotics. Molecular identification of the presump-
tive isolates based on the tuf gene specific primers con-
firmed them to be Enterococcus spp. Representatives of
the confirmed isolates are shown in Fig. 1. Attempt at
speciation of the isolates with primers specific for E. faeca-
lis, E. durans, E. casseliflavus, E. hirae and E. faecium
delineated them as follow: E. faecalis (12.5 %), E. hirea
(31.25 %), E. durans (18.75 %) and E. faecium (37.5 %) while
E. casseliflavus was not detected as shown in Figs. 2 and 3.
Antibiotic susceptibility
A very high multi-resistance to antibiotics tested was ob-
served among the isolates. All the isolates were resistant
to most of the drugs tested against them with vancomycin,
streptomycin and cloxacillin have 100 % resistance re-
spectively. Among the 12 antimicrobial agents tested, the
frequencies of resistances to penicillin G (91 %), clinda-
mycin (98.72 %), ciprofloxacin (77.5 %), erythromycin
(98.72 %), neomycin (93.8 %), amikacin (85 %), cephalo-
thin (86.3 %) were among the highest while those of
imipenem (16.3 %) and amoxicillin/clavulanate (20 %)
were least frequent. The phenotypic multi-resistance
patterns of the isolates are shown in Table 4 while the
percentage resistance is in Fig. 4. All Enterococcus iso-
lates were resistant to at least two different classes of
antibiotics, with 300 (93.8 %) isolates being resistant to
five or more antibiotics. Overall, all the isolates recov-
ered demonstrated relatively high resistance levels to
agents that are used in the farms which includes peni-
cillin, erythromycin that is selected by tylosin and quin-
olones (advocin).
Correlation between antibiotic resistance phenotype and
genotype
Specific resistance genes were detected in corresponding
phenotypic antibiotic-resistant isolates (Table 5) and some
of the detected resistance genes are shown in Figs. 5 and
6. The detected genes include those conferring resistance
Table 5 Predominant multi-resistance pattern observed among
the isolates






V = Vancomycin, CD = Clindamycin; S = Streptomycin, E = Erythromycin; CIP =
Ciprofloxacin; PG = Penicillin G; NE = Neomycin; IMI = Imipenem; KF =
Cephalothin; AK = Amikacin; AUG = Amoxicillin/Clavulanic acid
1 2 3 4 5 6 7 8 9 10 11 12 13
360bp
299bp
Fig. 4 Phenotypic antibiotic resistance of the Enterococcus isolates recovered from this study
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to streptomycin an aminoglycosides (strA), erythromycin
a macrolides (ermB), and vancomycin a glycopeptide
(vanB, vanC1, vanC2/3). The vanB, vanC1, vanC2/3,
ermB, and strA genes were present in majority of the iden-
tified species of Enterococcus that exhibited phenotypic
resistance.
Genetic prevalence of virulence genes among the isolates
Among the virulence genes tested, only ace, gelE and esp
genes were detected in all almost all the isolates that
were genetically profiled. The other virulence genes (cylA,
hylA, and efaA) were not detected. The prevalence of the
virulence genes detected among the isolates is shown in
Table 6. The frequencies of the virulence genes are; ace
(96.88 %), gelE (93.13 %) and esp (67.8 %). Fig. 7 represents
the gel picture of the ace and gylE detected while esp was
not shown.
Discussion
Enterococcus, which exist commensally in the gut of
warm-blooded animals and humans, are opportunistic
pathogens that cause a variety of community-acquired
and health care–associated infections, such as urinary
tract and intra-abdominal infections, bacteremia, and
endocarditis [26]. Previous reports have shown that epi-
demiologically distinct Enterococcus spp. possess viru-
lence genes that enable them to establish infections in
their host [27] as well as demonstrate high antimicrobial
resistance occasioned by their ability to genetically acquire
and transmit antimicrobial drug resistant determinants
among themselves and other bacteria in their environ-
ment [28]. Therefore, we characterized all isolates with re-
spect to these traits. Out of a total of 400 fecal samples
collected from breeder pig farms, presumptive isolates re-
covered from bile aesculine azide medium were 320 and
were confirmed as Enterococcus spp.by PCR targeting the
tuf gene of the genus Enterococcus. Further characterization
of the confirmed 320 isolates by species specific primers de-
lineated them into four species; E. faecium, E. hirae, E.
durans and E. faecalis in order of their prevalence. Our
findings are in partial agreement with those of Hwang[29]
who reported a preponderance of E.feacium and E.feacalis
in fecal samples of poultry and swine collected at slaughter-
houses in South Korea and [30].
The presence of 6 virulence-associated genes (gelE,
hylA, ace, esp, efaA and cylA) was investigated by using
gene specific primers that have been described elsewhere
[25]. Out of the 6 virulence genes investigated, only
three; ace, gelE and esp were detected among the 320
isolates. Our findings are in near agreement with that of
Diarra [31] who reported the presence of glyE in all iso-
lates they studied in broiler chicken but quite different
from that of Mannu [25] who did not detect gelE and
ace in meat, cheese and vegetable samples that they ana-
lyzed. The main role of both gelatinase and serine prote-
ase in enterococcal pathogenesis is thought to be in
582bp
1 2 3 4 5 6 7 8 9 10 11 12
Fig. 6 Gel image of amplicons obtained from erythromycin resistant isolates. Lane 1 is 100 bp ladder, lane 2 negative control and lanes 3 to 11




























Fig. 5 Gel electrophoresis of PCR products of vancomycin resistant isolates. Lane 1 is 100 bp ladder, lane 2 negative control and lanes 3 to 11 are
vanC2/3 (582 bp) positive samples
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providing nutrients to the bacteria by degrading host
tissue and also functions in biofilm formation [32].
Gelatinase (GelE) is an extracellular zinc metallo-
endopeptidase secreted by E. faecalis [33, 34]. It is able
to hydrolyse gelatin, casein, haemoglobin and other bio-
active peptides. The gene (gelE) encoding GelE is located
on the chromosome and is regulated in a cell-density-
dependent manner. Zou [35] reported also a moderately
high presence of efa, gelE and ace virulence genes
among E. faecalis isolated from swine in China.
The isolates were generally homogenous in terms of
presence of virulence-associated genes and it appears
from our study that the incidence of known virulence
factors in Enterococcus is generally high with majority of
the strains carrying more than one virulence determinant.
The genes encoding efaA, hylA and cylA were how-
ever not detected. According to Shankar [32], the esp
gene encodes an enterococcal surface protein (Esp),
which contributes to the colonization and infection of
the urinary tract by increasing attachment to epithelial
surfaces and biofilm production.
Besides having a huge arsenal of insusceptibilities to
physicochemical and environmental stresses [13], En-
terococcus generally possess a broad spectrum of natural
antibiotic resistances [26]. The propensity for multiple
antibiotic resistances is a hallmark of Enterococcus. All
Enterococcus are naturally (intrinsically) resistant to many
antimicrobial agents such as semisynthetic penicillins (e.g.,
oxacillin), cephalosporins of all classes, monobactams and
polymyxins [37]. Notably, most of the isolates in our study
were resistant to the antimicrobials in the panel. Multiple
drug resistances were observed among the isolates with
the commonest patterns being those of vancomycin,
erythromycin and streptomycin. In a study conducted by
Diarra [31] on the distribution of antimicrobial resistance
of Enterococcus spp. in broiler chicken in Canada, they
reported a very high level of antimicrobial resistances
among their isolates. However, they did not detect vanco-
mycin resistance among their isolates except in few species
of E. gallinarum where vanC gene was present making our
finds differ a bit from theirs. Similarly, Peters [38] also re-
ported a similar pattern of occurrence of multidrug resist-
ant strains in a study on assessment of species distribution
and antibiotic resistance patterns of enterococcal from
food of animal origin in Germany. Brown [39] has reported
that if glycopeptide resistant enterococci (GRE) are present
in an infected patient rather than an antibiotic-susceptible
strain, clinical treatment failure is increased by 20 % and
mortality is increased from 27 % to 52 %.
The very high level of resistance among the isolates
against ciprofloxacin is quite alarming as this is the drug
of choice in the treatment of several bacterial infections.
It is useful for treating chest, urinary tract, prostatitis,
gastroenteritis, bone and joint infections, and some sexu-
ally transmitted diseases. Our findings are also in agree-
ment with those of Zou [35] who reported a high level of
resistances to erythromycin and ciprofloxacin among En-
terococcus spp. isolated from swine in China.
The high prevalence of ciprofloxacin resistance could be
attributed to the use of advocin a veterinary approved drug
that has danofloxacin as it active ingredient. Danofloxacin
is a synthetic fluoroquinolone with broad spectrum anti-
bacterial activity and it is commonly used in the treatment
of respiratory disease in chickens, cattle and pigs. Since
there is similarity in structure and mode of action be-
tween ciprofloxacin and danofloxacin, the possibility of
cross resistance arising is very high. Genetic investiga-
tion of the isolates for the presence of resistance genes
yielded amplicons for the ermB, strA, vanB and vanC1/
2/3 respectively. The findings in this study are in agree-
ment with previously reported cases of high prevalence of
multiple resistances among enterococcal strains of animal
origin [40–50]. Noble [51] reported that the genes
320bp
1 2 3 4 5 6 7 8 9 10 11
Fig. 7 Agarose gel image of amplicons obtained from a multiplex PCR performed with four Primers specific for the ace and gelE virulent genes of
Enterococcus species isolated in this study. Lane 1 is 100 bp ladder, lane 2 negative control and lanes 3 to 13 (ace 320 and gelE 402) are
representatives of the positive isolates identified in this study
Table 6 Prevalence of virulent genes amplified from the study
isolates







efaA = E.faecalis antigen A; gelE = gelatinase Ace = Adhesion of collagen
in E.faecalis
Eesp = surface protein; cylA = cytolysin; hylE = hyaluronidase
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responsible for vancomycin resistance have the poten-
tial to be transferred to other gram-positive pathogens
such as Staphylococcus aureus thus intensifying the
public health threat associated with vancomycin and
methicillin-resistant S. aureus [52–54, 57–59]. Our find-
ings are also in line with those of Jackson [55] that
reported a very high level of aminoglycosides among en-
terococcal isolated from swine.
The prevalence of antimicrobial resistance among the
isolates according to species distribution appears homoge-
neous as no one species showed disparity with regards to
the antimicrobials tested. The high-level resistances among
the isolates to neomycin and streptomycin which are the
drugs of choice in therapeutic regiments for enterococcal
endocarditis should be a major cause of concerns.
Antibiotics may be disseminated into the environment
from both human and agricultural sources, including
excretion, flushing of old and out-of-date prescriptions,
medical waste, discharge from wastewater treatment fa-
cilities, leakage from septic systems and agricultural
waste-storage structures [56].
Any use of antibiotics will most likely select for drug-
resistant bacteria especially when applied at subtherapeutic
levels as in animal feed. Among the various uses for antibi-
otics, low-dose, prolonged courses of antibiotics among
food animals have the capacity of creating ideal selective
pressures for the evolution and selection of resistant
strains. Spread of resistance may occur by direct contact or
indirectly through food, water, and animal waste applica-
tion to farm fields. It could also be augmented greatly by
the horizontal transfer of genetic elements such as plas-
mids via bacterial mating (conjugation). For example,
Alexander [60], showed that drug-resistant Escherichia coli
was present on beef carcasses after evisceration and after
24 h in the chiller and in ground beef stored for 1 to 8 days.
Equally ciprofloxacin-resistant Campylobacter spp. have
been isolated from 10 % to 14 % of consumer chicken
products [61, 62] while de Boer [63], have reported the
presence of MRSA in 12 % of beef, veal, mutton, pork,
turkey, fowl, and game samples purchased in the consumer
market in the Netherlands as well as in cattle dairy prod-
ucts in Italy [64]. Equally disturbing are the reports of ex-
tensive antibiotic resistance among bacteria isolates,
including human pathogens, from farmed fish and market
shrimp [65–66].
Conclusion
The prevalence of multiple antibiotic resistance entero-
cocci from fecal samples of pigs is reported here. The
data presented showed that the Enterococcus strains that
were profiled have the capacity to cause infection as well
as having a wide genetic repertoire to survive under
antimicrobial pressure. These findings are relevant to
public health and contribute to future risk assessment of
antimicrobial resistance in zoonotic bacteria. A high-
level rate of resistance to aminoglycosides, macrolides
and vancomycin might pose a serious risk in hospitals,
as antimicrobial therapy in human medicine could be-
come more limited. These findings suggest that Entero-
coccus spp. from swine should be treated with utmost
caution as they could be reservoirs for antimicrobial re-
sistance and virulence genes.
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